CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 75934-76123 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T91454","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pilot testing of Ph-like ALL cases with and known genomic lesions using the Nanostring assay identified all but one case 46/47 (97.9%) with ABL class, JAK2, NTRK3 or TSLP fusions correctly."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T279","span":{"begin":0,"end":189},"obj":"Sentence"}],"text":"Pilot testing of Ph-like ALL cases with and known genomic lesions using the Nanostring assay identified all but one case 46/47 (97.9%) with ABL class, JAK2, NTRK3 or TSLP fusions correctly."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T153","span":{"begin":25,"end":28},"obj":"Phenotype"}],"attributes":[{"id":"A153","pred":"hp_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/HP_0006721"}],"text":"Pilot testing of Ph-like ALL cases with and known genomic lesions using the Nanostring assay identified all but one case 46/47 (97.9%) with ABL class, JAK2, NTRK3 or TSLP fusions correctly."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T401","span":{"begin":25,"end":28},"obj":"Disease"},{"id":"T402","span":{"begin":140,"end":143},"obj":"Disease"},{"id":"T32565","span":{"begin":25,"end":28},"obj":"Disease"},{"id":"T23946","span":{"begin":140,"end":143},"obj":"Disease"}],"attributes":[{"id":"A401","pred":"mondo_id","subj":"T401","obj":"http://purl.obolibrary.org/obo/MONDO_0004967"},{"id":"A402","pred":"mondo_id","subj":"T402","obj":"http://purl.obolibrary.org/obo/MONDO_0008692"},{"id":"A19525","pred":"mondo_id","subj":"T32565","obj":"http://purl.obolibrary.org/obo/MONDO_0004967"},{"id":"A64721","pred":"mondo_id","subj":"T23946","obj":"http://purl.obolibrary.org/obo/MONDO_0008692"}],"text":"Pilot testing of Ph-like ALL cases with and known genomic lesions using the Nanostring assay identified all but one case 46/47 (97.9%) with ABL class, JAK2, NTRK3 or TSLP fusions correctly."}